Drug intelligence / Profile preview

SAP-021-T1

Development stage: Unknown
Lead developer: Avata Biosciences
Modality: Small Molecules
Administration: Oral

Overview

SAP-021-T1 is an investigational, novel oral solid-dose (capsule) formulation of synthetic cannabidiol (CBD) developed by Avata Biosciences (formerly Sapient Therapeutics). It is one of two candidate formulations (alongside SAP-021-T2) designed to improve the pharmacokinetic profile and bioavailability of cannabidiol compared to existing oil-based solutions like Epidiolex. The drug is being developed via the FDA's 505(b)(2) regulatory pathway, leveraging the established safety and efficacy data of cannabidiol for the treatment of epilepsy-related seizure disorders, including Dravet syndrome and other treatment-resistant epilepsies. SAP-021-T1 has been evaluated in Phase 1 clinical trials to assess its relative bioavailability and the impact of food on its absorption in healthy volunteers.

Other names: synthetic cannabidiol capsule

Targets

GPR55 (G protein-coupled receptor 55)CNR1 (Cannabinoid receptor 1)ENT1 (Solute carrier family 29 member 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on SAP-021-T1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SAP-021-T1.

Explore the full profile